We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.42%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$10.9B
AUM Growth
-$8.58M
(-0.08%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-2.76%
Top 10 Holdings %
Top 10 Hldgs %
12.68%
Holding
1,304
New
197
Increased
373
Reduced
535
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kroger
KR
|
+$75.5M |
| 2 |
Sherwin-Williams
SHW
|
+$74.5M |
| 3 |
Under Armour
UAA
|
+$51.9M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$51.7M |
| 5 |
Bath & Body Works
BBWI
|
+$45.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$144M |
| 2 |
Oracle
ORCL
|
+$121M |
| 3 |
IBM
IBM
|
+$115M |
| 4 |
Apple
AAPL
|
+$104M |
| 5 |
Microsoft
MSFT
|
+$97.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.61% |
| 2 | Industrials | 12.68% |
| 3 | Financials | 11.35% |
| 4 | Technology | 11.06% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
26
DELISTED
Hologic
HOLX
| $67.8M | 0.62% |
2,053,144
-33,801
| -2% | -$1.04M |
|
27
Labcorp
LH
$26.1B
| $67.6M | 0.62% |
624,048
+76,680
| +14% | +$7.89M |
|
|
28
Pfizer
PFE
$153B
| $67.3M | 0.62% |
2,039,356
-4,543,013
| -69% | -$144M |
|
29
AT&T
T
$166B
| $67.2M | 0.62% |
2,723,344
-1,039,285
| -28% | -$26.4M |
|
30
Northrop Grumman
NOC
$82.2B
| $66M | 0.61% |
409,746
+111,636
| +37% | +$17.8M |
|
31
Elevance Health
ELV
$85.6B
| $65.5M | 0.6% |
424,247
+69,156
| +19% | +$9.85M |
|
32
Cardinal Health
CAH
$57B
| $65.1M | 0.6% |
721,384
+90,914
| +14% | +$7.83M |
|
33
Altria Group
MO
$109B
| $64.2M | 0.59% |
1,284,027
-364,549
| -22% | -$19.4M |
|
34
Cencora
COR
$63.2B
| $62.6M | 0.58% |
550,936
+158,090
| +40% | +$15.9M |
|
35
GE Aerospace
GE
$384B
| $62.5M | 0.58% |
526,026
-157,245
| -23% | -$18.7M |
|
36
Assurant
AIZ
$14.1B
| $58.7M | 0.54% |
955,591
+16,633
| +2% | +$1.05M |
|
37
Biogen
BIIB
$30.1B
| $58.7M | 0.54% |
138,908
-15,801
| -10% | -$6.23M |
|
38
Waste Management
WM
$91.3B
| $58M | 0.53% |
1,069,741
+33,001
| +3% | +$1.76M |
|
|
39
Microsoft
MSFT
$3.72T
| $57.8M | 0.53% |
1,421,217
-2,246,620
| -61% | -$97.8M |
|
|
40
Under Armour
UAA
$2.34B
| $57.5M | 0.53% |
1,424,216
+1,411,516
| +11,114% | +$51.9M |
|
41
HCA Healthcare
HCA
$89.3B
| $56.2M | 0.52% |
746,875
+228,108
| +44% | +$16.4M |
|
42
Aon
AON
$75.5B
| $55.9M | 0.51% |
581,552
-30,169
| -5% | -$2.92M |
|
43
Allstate
ALL
$67.1B
| $55.5M | 0.51% |
779,953
+74,146
| +11% | +$5.23M |
|
44
Boeing
BA
$186B
| $55.3M | 0.51% |
368,516
-194,369
| -35% | -$28.3M |
|
45
Wells Fargo
WFC
$265B
| $54.5M | 0.5% |
1,001,669
-1,466,117
| -59% | -$79.2M |
|
46
HP
HPQ
$26.7B
| $53.6M | 0.49% |
3,790,488
-534,733
| -12% | -$8.82M |
|
|
OCR
47
DELISTED
OMNICARE INC
OCR
| $53.6M | 0.49% |
695,301
+330,338
| +91% | +$25.1M |
|
48
Viatris
VTRS
$18.7B
| $53.5M | 0.49% |
900,621
-115,545
| -11% | -$6.59M |
|
49
Walmart Inc
WMT
$895B
| $53.4M | 0.49% |
1,949,166
-635,721
| -25% | -$18M |
|
50
Gilead Sciences
GILD
$167B
| $53M | 0.49% |
540,186
-480,961
| -47% | -$48.8M |
|
Similar funds
KK
VAI
UIM
Los Angeles Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Los Angeles Capital Management held 1,304 positions worth $10.9B, down 0.08% from $10.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Los Angeles Capital Management's Q1 2015 filing shows 197 new, 373 increased, 535 reduced and 98 closed positions. Its largest new stake was Robert Half: 718,345 shares worth $43.5M. The largest sale was Pfizer, an estimated $144M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.
- Los Angeles Capital Management's largest Q1 2015 buy was Robert Half: 718,345 shares worth $43.5M.
- Los Angeles Capital Management added most to Kroger in Q1 2015, an estimated $75.5M increase.
- Los Angeles Capital Management's biggest Q1 2015 reduction was Pfizer, cutting an estimated $144M.
- Los Angeles Capital Management fully exited SAFEWAY INC in Q1 2015, selling an estimated $16.3M.
- Los Angeles Capital Management's ten largest holdings make up 13% of its $10.9B portfolio in Q1 2015.
- Los Angeles Capital Management opened 197 new positions and closed 98 in Q1 2015.
- Los Angeles Capital Management's portfolio value fell 0.08% quarter-over-quarter to $10.9B.
Based on Los Angeles Capital Management's 13F filing for Q1 2015, filed 6 May 2015.